Abbott Diagnostics Canada and Canadian healthcare technology company Avricore Health Inc have presented a platform utilizing Abbott’s ID NowTM molecular testing device and Avricore’s HealthTabTM to test patients for COVID-19 and utilize the software’s ability to directly report results from the device automatically. Avricore is seeking a contract for the provision of licensing to fully activate the rapid detection, and track and trace technologies offered by the HealthTabTM test.